Turns out, pharmacy benefits managers are doing fine at controlling their costs for the new generation of cholesterol drugs. How? By limiting scripts to patients who are actually eligible for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback